199 related articles for article (PubMed ID: 6994784)
1. Hypotensive effect of guanfacine in essential hypertension: a comparison with clonidine.
Lauro R; Reda G; Spallone L; Anguissola AB
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):81S-82S. PubMed ID: 6994784
[No Abstract] [Full Text] [Related]
2. Comparison of guanfacine and clonidine as antihypertensive agents.
Jäättelä A
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):67S-70S. PubMed ID: 6994782
[TBL] [Abstract][Full Text] [Related]
3. [A new antihypertensive agent used in a clinical setting].
Wetzels E; Raschig A; Kaiser HJ
Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive effect of guanfacine: a double-blind cross-over trial compared with clonidine.
Distler A; Kirch W; Lüth B
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):49S-53S. PubMed ID: 6994778
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of guanfacine and clonidine in essential hypertension: a single-blind crossover study.
Miach PJ; Louis WJ
Med J Aust; 1980 Oct; 2(7):395-6. PubMed ID: 7005630
[TBL] [Abstract][Full Text] [Related]
6. Clonidine and guanfacine in hypertension.
Jain AK; Hiremath A; Michael R; Ryan JR; McMahon FG
Clin Pharmacol Ther; 1985 Mar; 37(3):271-6. PubMed ID: 3882307
[TBL] [Abstract][Full Text] [Related]
7. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
[TBL] [Abstract][Full Text] [Related]
8. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
Schäfer N; Knaup G
Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
[No Abstract] [Full Text] [Related]
9. Effects of clonidine and guanfacine in essential hypertension.
Farsang C; Varga K; Vajda L; Alföldi S; Kapocsi J
Clin Pharmacol Ther; 1984 Nov; 36(5):588-94. PubMed ID: 6386275
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine.
Jerie P
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):157S-164S. PubMed ID: 6994770
[No Abstract] [Full Text] [Related]
11. Comparison of guanfacine versus clonidine for efficacy, safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension.
Wilson MF; Haring O; Lewin A; Bedsole G; Stepansky W; Fillingim J; Hall D; Roginsky M; McMahon FG; Jagger P
Am J Cardiol; 1986 Mar; 57(9):43E-49E. PubMed ID: 3513530
[TBL] [Abstract][Full Text] [Related]
12. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
[No Abstract] [Full Text] [Related]
13. Comparative study of two antihypertensive agents: guanfacine and guanethidine.
Szám I; Kállay K
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786
[TBL] [Abstract][Full Text] [Related]
14. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)].
Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G
Arzneimittelforschung; 1980; 30(6):1005-7. PubMed ID: 6998487
[TBL] [Abstract][Full Text] [Related]
15. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension.
Manhem P; Hökfelt B
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):109S-114S. PubMed ID: 6994763
[No Abstract] [Full Text] [Related]
17. Guanfacine for hypertension.
Med Lett Drugs Ther; 1987 May; 29(740):49-50. PubMed ID: 2883560
[No Abstract] [Full Text] [Related]
18. Clinical dose-response studies with guanfacine (BS 100-141), a new antihypertensive agent.
MacCarthy P; Isaac P; Frost G; Freeman A; Stokes G
Clin Exp Pharmacol Physiol; 1978; 5(2):187-90. PubMed ID: 348364
[TBL] [Abstract][Full Text] [Related]
19. An ambulatory trial of guanfacine.
Mann S; Millar Craig MW; Melville DI; Cashman PM; Raftery EB
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):103S-107S. PubMed ID: 6994762
[TBL] [Abstract][Full Text] [Related]
20. Effects of single and multiple doses of guanfacine in essential hypertension.
Zamboulis C; Reid JL
Clin Pharmacol Ther; 1980 Dec; 28(6):715-21. PubMed ID: 7002428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
